Roivant Sciences Ltd. (ROIV) Insider Trading -- Recent Executive & Director Transactions
14 insiders reported 336 Form 4 transactions for Roivant Sciences Ltd. (ROIV) over the past 18 months (most recent 2026-10-05). Recent activity: Epperly Melissa B, (Director) Buy 17,750 shares, Epperly Melissa B, (Director) Sell 16,850 shares, Epperly Melissa B, (Director) Sell 900 shares, Torti Frank (President and Vant Chair) Buy 40,309 shares, Sukhatme Mayukh (President & CIO) Sell 46,879 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Epperly Melissa B, | Director | Buy | 17,750 | $79,165 |
| 2026-10-05 | Epperly Melissa B, | Director | Sell | 16,850 | $607,948 |
| 2026-10-05 | Epperly Melissa B, | Director | Sell | 900 | $32,913 |
| 2026-10-02 | Torti Frank | President and Vant Chair | Buy | 40,309 | $1.5M |
| 2026-10-02 | Sukhatme Mayukh | President & CIO | Sell | 46,879 | $1.7M |
| 2026-10-02 | Gline Matthew | CEO | Sell | 76,171 | $2.8M |
| 2026-10-02 | Venker Eric | President & Immunovant CEO | Buy | 200,000 | $770,000 |
| 2026-10-02 | Venker Eric | President & Immunovant CEO | Sell | 200,000 | $7.3M |
| 2026-09-22 | Pulik Richard | CFO | Sell | 2,129 | $84,670 |
| 2026-09-22 | Humes Jennifer | Chief Accounting Officer | Sell | 3,880 | $154,308 |
| 2026-09-18 | Fitzgerald Meghan | Director | Buy | 5,054 | $0 |
| 2026-09-18 | MANCHESTER KEITH S | Director | Buy | 5,054 | $0 |
| 2026-09-18 | MOMTAZEE JAMES C | Director | Buy | 5,054 | $0 |
| 2026-09-18 | Oren Ilan | Director | Buy | 5,054 | $0 |
| 2026-09-18 | Epperly Melissa B, | Director | Buy | 5,054 | $0 |
| 2026-09-18 | Gold Daniel Allen | Director | Buy | 5,054 | $0 |
| 2026-09-17 | Fitzgerald Meghan | Director | Sell | 4,712 | $186,972 |
| 2026-09-17 | Epperly Melissa B, | Director | Sell | 4,338 | $172,002 |
| 2026-09-17 | Fitzgerald Meghan | Director | Sell | 400 | $16,180 |
| 2026-09-17 | Epperly Melissa B, | Director | Sell | 600 | $24,228 |
| 2026-09-14 | MOMTAZEE JAMES C | Director | Sell | 2,905 | $118,931 |
| 2026-09-14 | Fitzgerald Meghan | Director | Sell | 1,743 | $71,358 |
| 2026-09-14 | Oren Ilan | Director | Sell | 2,378 | $97,355 |
| 2026-09-14 | Epperly Melissa B, | Director | Sell | 2,179 | $89,208 |
| 2026-09-14 | Gold Daniel Allen | Director | Sell | 5,133 | $210,145 |
Source: SEC Form 4 filings · as of 2026-10-05